Affiliation:
1. Department of Life Sciences, Food and Nutrition Science, Chalmers University of Technology, SE-41296 Gothenburg, Sweden
2. Department of Medical Sciences, Gastroenterology/Hepatology, Uppsala University, SE-75185 Uppsala, Sweden
3. Department of Animal Nutrition and Management, Swedish University of Agricultural Sciences, SE-75007 Uppsala, Sweden
4. Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, SE-75007 Uppsala, Sweden
Abstract
Background: A mechanistic understanding of the effects of dietary treatment in irritable bowel syndrome (IBS) is lacking. Our aim was therefore to investigate how fermentable oligo- di-, monosaccharides, and polyols (FODMAPs) and gluten affected gut microbiota and circulating metabolite profiles, as well as to investigate potential links between gut microbiota, metabolites, and IBS symptoms. Methods: We used data from a double-blind, randomized, crossover study with week-long provocations of FODMAPs, gluten, and placebo in participants with IBS. To study the effects of the provocations on fecal microbiota, fecal and plasma short-chain fatty acids, the untargeted plasma metabolome, and IBS symptoms, we used Random Forest, linear mixed model and Spearman correlation analysis. Results: FODMAPs increased fecal saccharolytic bacteria, plasma phenolic-derived metabolites, 3-indolepropionate, and decreased isobutyrate and bile acids. Gluten decreased fecal isovalerate and altered carnitine derivatives, CoA, and fatty acids in plasma. For FODMAPs, modest correlations were observed between microbiota and phenolic-derived metabolites and 3-indolepropionate, previously associated with improved metabolic health, and reduced inflammation. Correlations between molecular data and IBS symptoms were weak. Conclusions: FODMAPs, but not gluten, altered microbiota composition and correlated with phenolic-derived metabolites and 3-indolepropionate, with only weak associations with IBS symptoms. Thus, the minor effect of FODMAPs on IBS symptoms must be weighed against the effect on microbiota and metabolites related to positive health factors.
Funder
Swedish Research Council
Swedish Research Council for Environment Agricultural Sciences and Spatial Planning
Subject
Food Science,Nutrition and Dietetics
Reference97 articles.
1. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV;Drossman;Gastroenterology,2016
2. Fecal Microbiota Transplantation for Managing Irritable Bowel Syndrome;Mazzawi;Expert Rev. Gastroenterol. Hepatol.,2018
3. Chromogranin A Cell Density in the Rectum of Patients with Irritable Bowel Syndrome;Mazzawi;Mol. Med. Rep.,2012
4. Stress and the Gut: Pathophysiology, Clinical Consequences, Diagnostic Approach and Treatment Options;Konturek;J. Physiol. Pharmacol.,2011
5. Irritable Bowel Syndrome: The Role of Gut Neuroendocrine Peptides;Seim;Front. Biosci.-Elite,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献